- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/50 - Proteinases
Patent holdings for IPC class C12N 9/50
Total number of patents in this class: 1045
10-year publication summary
66
|
55
|
69
|
106
|
68
|
76
|
76
|
84
|
82
|
44
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novozymes A/S | 3311 |
62 |
The Regents of the University of California | 19839 |
24 |
Allergan, Inc. | 2361 |
16 |
Massachusetts Institute of Technology | 10019 |
14 |
Danisco US Inc. | 1100 |
13 |
University of Washington | 2315 |
13 |
The Board of Trustees of the Leland Stanford Junior University | 6380 |
12 |
DSM IP Assets B.V. | 5603 |
12 |
Ipsen Bioinnovation Limited | 41 |
12 |
President and Fellows of Harvard College | 5952 |
11 |
Codexis, Inc. | 796 |
11 |
California Institute of Technology | 3969 |
9 |
Lysando AG | 47 |
9 |
Sandoz AG | 1421 |
8 |
Alcresta Therapeutics, Inc. | 42 |
7 |
Amano Enzyme Inc. | 382 |
7 |
Jiangnan University | 1517 |
7 |
Endo Biologics Limited | 28 |
7 |
Kao Corporation | 4954 |
6 |
Boehringer Ingelheim RCV GmbH & Co KG | 57 |
6 |
Other owners | 779 |